ATE179610T1 - Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten - Google Patents

Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Info

Publication number
ATE179610T1
ATE179610T1 AT95910179T AT95910179T ATE179610T1 AT E179610 T1 ATE179610 T1 AT E179610T1 AT 95910179 T AT95910179 T AT 95910179T AT 95910179 T AT95910179 T AT 95910179T AT E179610 T1 ATE179610 T1 AT E179610T1
Authority
AT
Austria
Prior art keywords
treatment
composition
dependent diseases
ovarian estrogen
estrogen
Prior art date
Application number
AT95910179T
Other languages
German (de)
English (en)
Inventor
Gary D Hodgen
Robert F Williams
Daniel Grow
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Application granted granted Critical
Publication of ATE179610T1 publication Critical patent/ATE179610T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT95910179T 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten ATE179610T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/191,631 US5681817A (en) 1994-02-04 1994-02-04 Treatment of ovarian estrogen dependent conditions

Publications (1)

Publication Number Publication Date
ATE179610T1 true ATE179610T1 (de) 1999-05-15

Family

ID=22706258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95910179T ATE179610T1 (de) 1994-02-04 1995-02-02 Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten

Country Status (29)

Country Link
US (1) US5681817A (online.php)
EP (1) EP0785792B1 (online.php)
JP (1) JP3130048B2 (online.php)
KR (1) KR970700507A (online.php)
CN (1) CN1144486A (online.php)
AP (1) AP724A (online.php)
AT (1) ATE179610T1 (online.php)
AU (1) AU689229B2 (online.php)
BG (1) BG62238B1 (online.php)
BR (1) BR9506606A (online.php)
CA (1) CA2182183C (online.php)
CZ (1) CZ291709B6 (online.php)
DE (1) DE69509544T2 (online.php)
DK (1) DK0785792T3 (online.php)
ES (1) ES2132645T3 (online.php)
FI (1) FI963036L (online.php)
GR (1) GR3030164T3 (online.php)
HU (1) HUT74622A (online.php)
LT (1) LT4182B (online.php)
LV (1) LV11782B (online.php)
MD (1) MD1432C2 (online.php)
NZ (1) NZ281441A (online.php)
OA (1) OA10777A (online.php)
PL (1) PL178273B1 (online.php)
RO (1) RO117420B1 (online.php)
RU (1) RU2110274C1 (online.php)
SK (1) SK96296A3 (online.php)
TJ (1) TJ242B (online.php)
WO (1) WO1995020972A1 (online.php)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282118B6 (sk) * 1994-07-22 2001-11-06 The Medical College Of Hampton Roads Použitie antagonistu hormónu uvoľňujúceho gonadotropíny
US5780435A (en) * 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
CA2306110A1 (en) 1997-10-17 1999-04-29 Mochida Pharmaceutical Co., Ltd. Therapeutic agent of uterine leiomyoma, containing dienogest as effective ingredient
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6417214B1 (en) * 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
AR025457A1 (es) * 1999-08-31 2002-11-27 Schering Ag Mesoprogestinas (moduladores de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
EP1330257B1 (en) * 2000-10-30 2005-08-31 University Of Zurich Gnrh analogues for treatment of urinary incontinence
US6958142B2 (en) * 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
US8257742B2 (en) * 2005-02-17 2012-09-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates for treating endometriosis
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
TWI455716B (zh) * 2006-10-24 2014-10-11 Repros Therapeutics Inc 選擇性黃體激素受體調節劑用於製造治療雌激素依賴性病症之藥物的用途
ES2643318T3 (es) * 2006-10-24 2017-11-22 Repros Therapeutics Inc. Composiciones y métodos para suprimir la proliferación endometrial
WO2008144143A1 (en) * 2007-05-14 2008-11-27 Drugtech Corporation Endometriosis treatment
JP5555631B2 (ja) * 2007-09-20 2014-07-23 ラピドット メディカル インポート アンド マーケティング リミテッド ミフェプリストンによる子宮平滑筋腫、平滑筋腫、筋腫、子宮類線維腫、子宮内膜症、または腺筋症を治療するための組成物および手段
RU2359684C1 (ru) * 2008-01-23 2009-06-27 Закрытое акционерное общество "СКАЙ ЛТД" Способ лечения эндометриоза
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US4780461A (en) 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
ES2054784T3 (es) 1987-08-08 1994-08-16 Akzo Nv Un metodo para la fabricacion de un implante.
DE3744054A1 (de) 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
DE3921059A1 (de) 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
WO1991014704A2 (en) 1990-03-16 1991-10-03 Applied Research Systems Ars Holding N.V. Treatment of polycystic ovarian disease
US6827050B2 (en) 2001-12-21 2004-12-07 Caterpillar Inc Fluid control valve actuating system
US7283632B2 (en) 2003-09-09 2007-10-16 The Boeing Company Unauthorized access embedded software protection system

Also Published As

Publication number Publication date
NZ281441A (en) 1999-09-29
RO117420B1 (ro) 2002-03-29
BG100766A (bg) 1997-06-30
FI963036A0 (fi) 1996-08-01
FI963036A7 (fi) 1996-08-01
DE69509544D1 (de) 1999-06-10
LT96133A (en) 1997-01-27
SK96296A3 (en) 1997-07-09
FI963036L (fi) 1996-08-01
ES2132645T3 (es) 1999-08-16
PL315792A1 (en) 1996-12-09
LV11782A (lv) 1997-06-20
DK0785792T3 (da) 1999-10-18
CA2182183C (en) 2003-09-16
EP0785792B1 (en) 1999-05-06
LT4182B (en) 1997-06-25
AP9600840A0 (en) 1996-07-31
US5681817A (en) 1997-10-28
CZ291709B6 (cs) 2003-05-14
LV11782B (en) 1997-12-20
HU9601969D0 (en) 1996-09-30
CZ210396A3 (en) 1997-05-14
KR970700507A (ko) 1997-02-12
MD1432B2 (en) 2000-03-31
CN1144486A (zh) 1997-03-05
AP724A (en) 1999-01-18
EP0785792A1 (en) 1997-07-30
AU1838695A (en) 1995-08-21
MD1432C2 (ro) 2000-09-30
BG62238B1 (bg) 1999-06-30
WO1995020972A1 (en) 1995-08-10
DE69509544T2 (de) 1999-09-02
EP0785792A4 (online.php) 1997-07-30
CA2182183A1 (en) 1995-08-10
PL178273B1 (pl) 2000-03-31
JP3130048B2 (ja) 2001-01-31
TJ242B (en) 1999-11-24
AU689229B2 (en) 1998-03-26
OA10777A (en) 2002-12-23
RU2110274C1 (ru) 1998-05-10
GR3030164T3 (en) 1999-08-31
BR9506606A (pt) 1997-09-09
JPH09508418A (ja) 1997-08-26
HUT74622A (en) 1997-01-28

Similar Documents

Publication Publication Date Title
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
EP0709090A3 (en) Compositions for the treatment of resistant tumors
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69724016D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen erkrankungen der atemwege
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69526684D1 (de) Begasungsrührwerk zur Behandlung von Metallschmelzen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
FI953180L (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
DE69734513D1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
EP1117395A4 (en) COMPOUNDS FOR THE TREATMENT OF ESTROGEN-RELATED DISEASES, METHODS OF PRODUCTION AND METHODS OF USE
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69614739D1 (de) Pflaster zur Behandlung von Pflanzen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee